Baseline Serum Prolactin in Drug-naive, First-episode Schizophrenia and Outcome at Five Years: Is it a Predictive Factor?

| April 8, 2012 | 0 Comments

 

by Amresh Shrivastava; Megan Johnston; Yves Bureau; and Nilesh Shah
Dr. Shrivastava is Executive Director of the Mental Health Foundation of India (PRERANA Charitable Trust, Mumbai, India) and currently from the Department of Psychiatry at the University of Western Ontario and Lawson Health Research Centre, London, Ontario, Canada; Ms. Johnston is from the University of Toronto, Ontario, Canada; Dr. Bureau is Research Scientist (Associate Scientist/Director of Inferential Statistics-Imaging) at Lawson Health Research Institute and Adjunct Professor (Psychology) at the University of Western Ontario, London, Ontario, Canada; and Dr. Shah is Professor of Psychiatry at LTMG Hospital, University of Mumbai, India.

Innov Clin Neurosci. 2012;9(4):17–21

The content you are trying to view is restricted to registered members only.
Membership to Innovations in Clinical Neuroscience is free, so please consider becoming a member today.
Thank you
ICNS Online Editor
Please Login or Register for access.

Tags: , , ,

Category: Original Research, Psychiatry, Schizophrenia

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.